Conditions: Bacteremia Gram-Positive Bacterial Infections
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 61
Healthy volunteers: no

Brief summary:
This study will treat hemodialysis patients who have a central catheter that is thought to be infected with a specific bacteria (Gram positive bacteria).

Detailed description:
Pfizer suspended enrollment on 21 August 2006 as a precautionary measure in light of the mortality imbalance seen in a similar study, and terminated the study on April 6, 2007 due to factors affecting the timeline to completion, such as slow enrollment and inclusion of sufficient evaluable subjects.

Arms:

Interventions: intervention 1: Cefazolin IV intervention 2: Linezolid IV intervention 3: Vancomycin (IV)
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: